Business Standard

Alembic Pharmaceuticals Ltd Announcements

BY EXCHANGE :

ANNOUNCEMENTSUBJECTATTACHMENTBROADCAST DATE
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please find attached herewith Stock Exchange intimation received from our RTA.10/10/2024
Successful Completion Of USFDA Inspection At Alembic Pharmaceuticals Limited Oncology (Injectable And Oral Solid) Formulation Facility (F-2) At Panelav. Please find attached the intimation for completion of USFDA inspection at Compan...Read More09/10/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please find attached herewith stock exchange intimation received from our RTA.07/10/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Please find attached herewith the Certificate under Regulation 74(5) of the SEBI...Read More07/10/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release Please find attached the final approval received from USFDA for Lamotrigine Exte...Read More03/10/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please find attached herewith the intimation received from our RTA.01/10/2024
Announcement under Regulation 30 (LODR)-Change in Management Please find attached herewith Intimation regarding Change in Senior Management P...Read More30/09/2024
Alembic Pharmaceuticals Limited Received An Establishment Inspection Report (EIR) For Its Oral Solid Formulation Facility(F-1) At Panelav We are pleased to inform the exchanges that the Company has received an Establis...Read More27/09/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release Alembic Pharmaceuticals receives USFDA Final Approval for Paliperidone Extended ...Read More27/09/2024
Closure of Trading Window Kindly find attached herewith the Intimation for closure of trading window.26/09/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please find attached herewith the intimation received from RTA.20/09/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please find attached the intimation for issuance of Duplicate Share Certificate.19/09/2024
Intimation Under Regulation 30 Of SEBI (Listing Obligations AndDisclosure Requirements) Regulations 2015 (SEBI Listing Regulations2015) Please find attached the specimen copy of the letter sent to the shareholders h...Read More19/09/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication Please find attached herewith a copy of advertisement related to notice of loss ...Read More18/09/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication Please find attached herewith copy of advertisement related to Notice of Loss of...Read More18/09/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please find attached herewith the intimation received from our RTA.16/09/2024
Announcement under Regulation 30 (LODR)-Change in Management Please find attached herewith the Intimation regarding appointment of Senior Man...Read More16/09/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please find attached herewith the Intimation received from our RTA.12/09/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release Alembic Pharmaceuticals receives USFDA Final Approval for Albendazole Tablets US...Read More05/09/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please find attached herewith the intimation received from our RTA.02/09/2024

Load more